Income investing can be a particularly effective investment strategy for those seeking to achieve financial independence. This is because, by buying high-quality businesses and sticking with the strategy for the long haul, your brokerage account can be flooded with passive income that can be used to pay bills.

When looking for excellent income investing opportunities, the Switzerland-based pharmaceutical company Novartis (NYSE: NVS) moves to the top of the list. Let's examine the company's fundamentals and valuation to see why this is the case.

Novartis' $209 billion market capitalization makes it the eighth-biggest drugmaker in the world. Unsurprisingly, the company's portfolio of dozens of prescription medicines contained 14 that fit in the blockbuster category in 2022 (i.e., they generated at least $1 billion in net sales).

Continue reading

Source Fool.com